Please find below articles from Cypriot authors and co-authors that were published in the European Journal of Neurology
-
-
Paper of the MonthEAN NewsFeatured SliderA Round Table on the Paper of the month: Can beta-receptor agonists prevent PD?
For November 2017, we have selected: Mittal S, Bjørnevik K, Im DS, et al. ß2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease. Science 2017;140:2295-2305. Disturbed proteostasis of α-synuclein is now thought to play a critical role in the pathogenesis of Parkinson’s disease (PD). Physiological functions of this protein include synaptic transport as well as involvement in the metabolism of membrane phospholipids, and in the differentiation and survival of dopaminergic neurons. -
The actual and ongoing agenda of the EAN – NeuroOncology Panel was presented during the EAN 2017 in Amsterdam at the Panel meeting. The following activities were discussed in detail: Guidelines, provided by the EAN-Scientific Panels, are one… Continue Reading -
ResearchScientific panels reports
Activities of the Subspeciality Scientific Panel on Dementia and Cognitive Disorders Panel 2016-2017
SP on Dementia and Cognitive Disorders Panel met during recent EAN Congress in Amsterdam. Co-chairs Reinhold Schmidt from Austria and Jakub Hort from Czech Republic welcomed members and announced that Prof. Dafin Muresanu from Romania has been appointed as… Continue Reading -
The Panel met at the EAN Congress in Amsterdam and the Co-Chairs presented the main points from the Panel Chairs meeting. It was agreed that the Panel would approach all members to suggest a Neurologist in training to join… Continue Reading
-
ResearchScientific CornerTop ArticlesA new guideline on cerebral venous thrombosis – Guideline paper by José Ferro
A new guideline on cerebral venous thrombosis (CVT) diagnosis and treatment issued by the European Stroke Organization (ESO) and endorsed by the European Academy of Neurology (EAN) was recently published in ESO (long version) and EAN (abbreviated version) official journals [1, 2]. -
ResearchScientific CornerEAN Task Force for Rare Neurological Diseases – Report from the Teaching Course
It is a pleasure to share with the European neurological community the outcome of the first teaching course for rare neurological diseases. The course took place in Cluj-Napoca, Romania, from 7th to 9th September 2017. -
Paper of the MonthEAN NewsFeatured SliderPaper of the month: Beneficial effects of lamotrigine in myotonias
For October 2017, we have selected: Andersen G, Hedermann G, Witting N, Duno M, Andersen H, Vissing J. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain 2017;140:2295-2305. Patients with myotonia congenita and paramyotonia congenita can be disabled by the myotonic phenomenon in the activities of daily living, with a huge impact on their quality of life. -
ResearchScientific panels reports
Activities 2016-2017 of the EAN Scientific Panel Coma and chronic disorders of consciousness
Summary of activities in the last 12 months The Panel reviewed currently used functional scores (K Diserens, Lausanne CH), posted one Neurology update (R. Formisano, Rome I), and submitted a review of relevant literature in the last 20 years for… Continue Reading -
ResearchScientific panels reports
Activities of the EAN Scientific Panel Clinical Neurophysiology 2016/2017
Josep Valls-Sole summarized the activities of members of the panel approved for Amsterdam: Novelties in hands-on courses were the inclusion of surface EMG in the hands on course of EMG (together with conventional and single fiber). Therefore, there were 3… Continue Reading -
SP Pain met during recent EAN Congress in Amsterdam. Co-chair Nadine Attal from France welcomed members and presented last year panel’s activities. Last year was successful. SP Pain co-chairs Nadine Attal and Giorgio Cruccu had, together with members of… Continue Reading
-
ResearchScientific panels reports
Activities of the EAN Scientific Panel Neurotraumatology 2016/2017
SP Neurotraumatology met during recent EAN Congress in Amsterdam. Co-chairs Pieter Vos from the Netherlands and Oliver Kastrup from Germany welcomed members and introduced Dafin Muresanu from Romania, as a new liaison officer between the scientific committee and scientific… Continue Reading -
ResearchScientific Corner
Interview with Holm Graessner on the European Reference Networks – following the Meeting of the Rare Neurologic Diseases Task Force at EAN 2017
Antonio Federico: What are the aims of your ERN? Holm Graessner: The aims of the European Reference Network for Rare Neurological Diseases (ERN-RND network) will be: To increase the overall percentage of rare neurological disease patients with a final diagnosis through information dissemination, improved access to expertise centres, introduction of an EQA scheme for genetic RND diagnostics and virtual multidisciplinary consultation -
Paper of the MonthFeatured SliderPaper of the month: Long-term opioid therapy is not beneficial in patients with polyneuropathy
For September 2017, we have selected: Hoffman EM, Watson JC, St Sauver J, Staff NP, Klein CJ. Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy. JAMA Neurology 2017;74:773-779. Neuropathic pain is a common symptom in polyneuropathy that can be difficult to manage. Opioids are usually recommended as second-line treatment, with primary care physicians being mainly involved in opioid prescription. -
ResearchScientific CornerInterview with Helen Cross on the European Reference Networks – following the Meeting of the Rare Neurologic Diseases Task Force at EAN 2017
Antonio Federico: What are the aims of your ERN? Helen Cross: The objectives of the EpiCARE network will be: To improve accessibility of detailed diagnostics to individuals of all ages with rare and complex epilepsies across Europe, including clinical evaluation and investigation.